Abstract
In the investigation 97 children were included, suffering cystic lymphatic malformations, who were treated in 2011 — 2016 yrs. Lymphatic malformations were classified, depending on the cysts size: macrocystic, microcystic, and the mixed. Sclerotherapy, using biological preparation ОК—432, was conducted in 80 (82.5%) children, surgical excision of lymphatic malformations — in 10 (10.3%), the combined treatment — in 7 (7.2%).
MeSH terms
-
Adolescent
-
Antineoplastic Agents / therapeutic use*
-
Child
-
Child, Preschool
-
Combined Modality Therapy
-
Female
-
Head / pathology
-
Head / surgery
-
Humans
-
Infant
-
Lymphocele / drug therapy*
-
Lymphocele / pathology
-
Lymphocele / surgery*
-
Male
-
Neck / pathology
-
Neck / surgery
-
Picibanil / therapeutic use*
-
Retrospective Studies
-
Sclerosing Solutions / therapeutic use*
-
Sclerotherapy / methods*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Sclerosing Solutions
-
Picibanil